 | • レポートコード：PMR20MY099 • 出版社/出版日：Persistence Market Research / 2020年3月9日 • レポート形態：英文、PDF、307ページ • 納品方法：Eメール • 産業分類：生命科学&トランスフォーメーショナルヘルス |
| Individual User（1名用） | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Multi User（5名用） | ￥1,124,800 (USD7,600) | ▷ お問い合わせ |
| Corporate User（企業用） | ￥1,568,800 (USD10,600) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の注射型ドラッグデリバリー市場について調査・分析し、エグゼクティブサマリー、市場概要、市場動向、市場成功要因、市場需要分析及び予測、技術分析、市場背景、北米、中南米、ヨーロッパ市場分析などを含め、以下の構成でお届け致します。 ・世界の注射型ドラッグデリバリー市場：エグゼクティブサマリー ・世界の注射型ドラッグデリバリー市場：概要 ・世界の注射型ドラッグデリバリー市場：動向 ・世界の注射型ドラッグデリバリー市場：成功要因 ・世界の注射型ドラッグデリバリー市場：需要分析及び予測 ・世界の注射型ドラッグデリバリー市場：技術分析 ・世界の注射型ドラッグデリバリー市場：背景 ・北米の注射型ドラッグデリバリー市場：分析及び予測 ・中南米の注射型ドラッグデリバリー市場：分析及び予測 ・ヨーロッパの注射型ドラッグデリバリー市場：分析及び予測 … |
Injectable Drug Delivery Market: Scope of the Report
Persistence Market Research (PMR) recently published a market study on the global injectable drug delivery market. The study provides detailed assessment on key market dynamics, including the drivers, trends, opportunities, restraints, and detailed information about the injectable drug delivery market structure. The market study presents exclusive information about how the injectable drug delivery market will grow during the forecast period of 2019-2029.
Key indicators of market growth, which include Year-on-Year (Y-o-Y) growth of the market and compounded annual growth rate (CAGR) are explained in PMR’s study in a comprehensive manner. Other information includes pricing analysis, which helps in deep understanding of the pricing details by researchers, suppliers, manufactures, and distributors. Other information contains volume analysis, which includes year-wise growth of the injectable drug delivery market during the forecast period. This information can help readers understand the quantitative growth prospects of the injectable drug delivery market for the forecast period.
The study is relevant for service providers, suppliers, distributors, and investors, and can help them in developing appropriate strategies to grow in the market. Business researcher, shareholders, and industry experts can leverage the information and data presented in PMR’s study.
The study also includes statistics as well as facts related to the macroeconomic factors that are impacting developments in the injectable drug delivery market. It also offers actionable insights based on future trends in the injectable drug delivery market. Furthermore, small businesses and new entrants in the injectable drug delivery market too can make use of the information presented in this study, based on which, they can make appropriate business decisions in order to gain momentum in the market.
Key Questions Answered in PMR’s Injectable Drug Delivery Market Report
Which regions will continue to remain the most profitable regional markets for injectable drug delivery market players?
Which factors will induce a change in the growth of the injectable drug delivery market during the assessment period?
What are the different opportunities available for emerging players in the injectable drug delivery market?
How are supply-side and demand-side drivers impacting the injectable drug delivery market?
How will changing trends impact the injectable drug delivery market?
How can market players capture the low-hanging opportunities in the injectable drug delivery market in developed regions?
Which companies are leading the injectable drug delivery market?
What are the winning strategies of stakeholders in the injectable drug delivery market to upscale their position in this landscape?
Injectable Drug Delivery Market: Research Methodology
In PMR’s study, a unique research methodology is utilized to conduct extensive research on the growth of the injectable drug delivery market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts ensure accuracy and reliability of the conclusions.
Secondary resources referred to by analysts during the production of the injectable drug delivery market study include statistics from government healthcare organizations, medicinal journals, research journals, press releases, annual reports, white papers, directories, and databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.
Comprehensive information acquired from primary resources and secondary resources acts as a validation from companies in the injectable drug delivery market, and makes PMR’s projection on the growth prospects of the injectable drug delivery market more accurate and reliable.
レポート目次1. Executive Summary
1.1. Global Market Outlook
1.2. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
4. Key Success Factors
4.1. Global Pharmaceutical Outlook
4.2. PEST Analysis
4.3. Key Disease Epidemiology
4.4. Parenteral Drugs Pipeline Assessment
4.5. Regulatory Landscape
4.6. Supply Chain analysis
5. Global Injectable Drug Delivery Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Key Technologies Assessment
6.1. Under Clinical Development Injectable Drug Delivery Technologies
6.2. Commercialized Injectable Drug Delivery Technologies
7. Market Background
7.1. Macro-Economic Factors
7.2. Forecast Factors – Relevance & Impact
7.3. Market Dynamics
7.3.1. Drivers
7.3.2. Restraints
7.3.3. Opportunity Analysis
8. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014 – 2018
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029
8.3.1. Self-Injectors
8.3.1.1. Single Chamber Self Injectors
8.3.1.2. Dual Chamber Self Injectors
8.3.2. Needle Free Injectors
8.3.2.1. Pre Filled Needle Free Injectors
8.3.2.2. Fill-Able Needle free Injectors
8.3.3. Auto Injectors
8.3.3.1. Prefilled Auto Injectors
8.3.3.2. Fill-Able Auto Injectors
8.3.4. Wearable Injectors
8.3.4.1. Wearable Patch Injectors
8.3.4.2. Off-body Worn Injectors
8.3.5. Insulin Pens
8.3.5.1. Reusable Insulin Pens
8.3.5.2. Disposable Insulin Pens
8.3.5.3. Smart Insulin Pen Caps
8.4. Market Attractiveness Analysis By Product Type
9. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Technology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2014 – 2018
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2019 – 2029
9.3.1. Non-Smart Injectors
9.3.2. Smart Injectors
9.3.3. Artificial Intelligence (AI) and Machine Learning Integrated
9.3.4. Near Field Communication (NFC)
9.3.5. Cloud Computing
9.3.6. Bluetooth
9.4. Market Attractiveness Analysis By Technology
10. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Indication
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By Indication, 2014 – 2018
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2019 – 2029
10.3.1. Anaphylaxis/ Asthma
10.3.2. Diabetes
10.3.3. Cardiovascular Diseases
10.3.4. Multiple Sclerosis
10.3.5. Rheumatoid Arthritis
10.3.6. Cancer
10.3.7. Trauma and Emergency
10.3.8. Others
10.4. Market Attractiveness Analysis By Indication
11. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Usage
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Mn) Analysis By Usage, 2014 – 2018
11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Usage, 2019 – 2029
11.3.1. Disposable Injectors
11.3.2. Reusable Injectors
11.4. Market Attractiveness Analysis By Usage
12. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014 – 2018
12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029
12.3.1. Hospital Pharmacies
12.3.2. Drug Stores
12.3.3. Retail Pharmacies
12.3.4. Online Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029, by Region
13.1. Introduction
13.2. Historical Market Size (US$ Mn) Analysis By Region, 2014 – 2018
13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (MEA)
13.4. Market Attractiveness Analysis By Region
14. North America Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
14.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
14.4.1. By Country
14.4.1.1. U.S.
14.4.1.2. Canada
14.4.2. By Product Type
14.4.3. By Technology
14.4.4. By Indication
14.4.5. By Usage
14.4.6. By Distribution Channel
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product Type
14.5.3. By Technology
14.5.4. By Indication
14.5.5. By Usage
14.5.6. By Distribution Channel
15. Latin America Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
15.4. Market Size (US$ Mn) and Volume Forecast By Market Taxonomy, 2019 – 2029
15.4.1. By Country
15.4.1.1. Brazil
15.4.1.2. Argentina
15.4.1.3. Mexico
15.4.1.4. Rest of Latin America
15.4.2. By Product Type
15.4.3. By Technology
15.4.4. By Indication
15.4.5. By Usage
15.4.6. By Distribution Channel
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product Type
15.5.3. By Technology
15.5.4. By Indication
15.5.5. By Usage
15.5.6. By Distribution Channel
16. Europe Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
16.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
16.4.1. By Country
16.4.1.1. Germany
16.4.1.2. U.K.
16.4.1.3. France
16.4.1.4. France
16.4.1.5. Italy
16.4.1.6. Spain
16.4.1.7. Russia
16.4.1.8. Rest of Europe
16.4.2. By Product Type
16.4.3. By Technology
16.4.4. By Indication
16.4.5. By Usage
16.4.6. By Distribution Channel
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product Type
16.5.3. By Technology
16.5.4. By Indication
16.5.5. By Usage
16.5.6. By Distribution Channel
17. South Asia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
17.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
17.4.1. By Country
17.4.1.1. India
17.4.1.2. Thailand
17.4.1.3. Indonesia
17.4.1.4. Malaysia
17.4.1.5. Rest of South Asia
17.4.2. By Product Type
17.4.3. By Technology
17.4.4. By Indication
17.4.5. By Usage
17.4.6. By Distribution Channel
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Product Type
17.5.3. By Technology
17.5.4. By Indication
17.5.5. By Usage
17.5.6. By Distribution Channel
18. East Asia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
18.1. Introduction
18.2. Pricing Analysis
18.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014 – 2018
18.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
18.4.1. By Country
18.4.1.1. China
18.4.1.2. Japan
18.4.1.3. South Korea
18.4.2. By Product Type
18.4.3. By Technology
18.4.4. By Indication
18.4.5. By Usage
18.4.6. By Distribution Channel
18.5. Market Attractiveness Analysis
18.5.1. By Country
18.5.2. By Product Type
18.5.3. By Technology
18.5.4. By Indication
18.5.5. By Usage
18.5.6. By Distribution Channel
19. Oceania Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
19.1. Introduction
19.2. Pricing Analysis
19.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
19.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
19.4.1. By Country
19.4.1.1. Australia
19.4.1.2. New Zealand
19.4.2. By Product Type
19.4.3. By Technology
19.4.4. By Indication
19.4.5. By Usage
19.4.6. By Distribution Channel
19.5. Market Attractiveness Analysis
19.5.1. By Country
19.5.2. By Product Type
19.5.3. By Technology
19.5.4. By Indication
19.5.5. By Usage
19.5.6. By Distribution Channel
20. Middle East and Africa Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
20.1. Introduction
20.2. Pricing Analysis
20.3. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2014 – 2018
20.4. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 – 2029
20.4.1. By Country
20.4.1.1. GCC Countries
20.4.1.2. Turkey
20.4.1.3. Northern Africa
20.4.1.4. South Africa
20.4.1.5. Rest of Middle East and Africa
20.4.2. By Product Type
20.4.3. By Technology
20.4.4. By Indication
20.4.5. By Usage
20.4.6. By Distribution Channel
20.5. Market Attractiveness Analysis
20.5.1. By Country
20.5.2. By Product Type
20.5.3. By Technology
20.5.4. By Indication
20.5.5. By Usage
20.5.6. By Distribution Channel
21. Key & Emerging Countries Analysis
21.1. U.S. Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.1.1. Introduction
21.1.2. Historical Market Size (US$ Mn) & Volume Units Trend Analysis By Market Taxonomy, 2014 – 2018
21.1.3. Market Size (US$ Mn) & Volume Units Forecast By Market Taxonomy, 2019 – 2029
21.1.3.1. By Product Type
21.1.3.2. By Technology
21.1.3.3. By Indication
21.1.3.4. By Usage
21.1.3.5. By Distribution Channel
21.1.4. Market Attractiveness Analysis
21.2. Canada Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.3. Brazil Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.4. Argentina Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.5. Mexico Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.6. Germany Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.7. U. K. Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.8. France Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.9. Italy Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.10. Spain Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.11. BENELUX Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.12. Russia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.13. China Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.14. Japan Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.15. South Korea Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.16. Australia Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.17. New Zealand Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.18. South Africa Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.19. GCC Countries Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
21.20. Turkey Countries Injectable Drug Delivery Market Analysis 2014-2018 and Forecast 2019-2029
22. Market Structure Analysis
22.1. Market Analysis by Tier of Companies (Injectable Drug Delivery)
22.2. Market Share Analysis of Top Players
23. Competition Analysis
23.1. Competition Dashboard
23.2. Competition Deep Dive
23.2.1. Eli Lilly and Company
23.2.1.1. Overview
23.2.1.2. Product Portfolio
23.2.1.3. Profitability by Market Segments (Product/Channel/Region)
23.2.1.4. Sales Footprint
23.2.1.5. Strategy Overview
23.2.1.5.1. Marketing Strategy
23.2.1.5.2. Product Strategy
23.2.1.5.3. Channel Strategy
23.2.2. Biocon
23.2.2.1. Overview
23.2.2.2. Product Portfolio
23.2.2.3. Profitability by Market Segments (Product/Channel/Region)
23.2.2.4. Sales Footprint
23.2.2.5. Strategy Overview
23.2.2.5.1. Marketing Strategy
23.2.2.5.2. Product Strategy
23.2.2.5.3. Channel Strategy
23.2.3. Becton, Dickinson & Company
23.2.3.1. Overview
23.2.3.2. Product Portfolio
23.2.3.3. Profitability by Market Segments (Product/Channel/Region)
23.2.3.4. Sales Footprint
23.2.3.5. Strategy Overview
23.2.3.5.1. Marketing Strategy
23.2.3.5.2. Product Strategy
23.2.3.5.3. Channel Strategy
23.2.4. West Pharmaceutical Services, Inc.
23.2.4.1. Overview
23.2.4.2. Product Portfolio
23.2.4.3. Profitability by Market Segments (Product/Channel/Region)
23.2.4.4. Sales Footprint
23.2.4.5. Strategy Overview
23.2.4.5.1. Marketing Strategy
23.2.4.5.2. Product Strategy
23.2.4.5.3. Channel Strategy
23.2.5. Johnson & Johnson
23.2.5.1. Overview
23.2.5.2. Product Portfolio
23.2.5.3. Profitability by Market Segments (Product/Channel/Region)
23.2.5.4. Sales Footprint
23.2.5.5. Strategy Overview
23.2.5.5.1. Marketing Strategy
23.2.5.5.2. Product Strategy
23.2.5.5.3. Channel Strategy
23.2.6. Antares Pharma
23.2.6.1. Overview
23.2.6.2. Product Portfolio
23.2.6.3. Profitability by Market Segments (Product/Channel/Region)
23.2.6.4. Sales Footprint
23.2.6.5. Strategy Overview
23.2.6.5.1. Marketing Strategy
23.2.6.5.2. Product Strategy
23.2.6.5.3. Channel Strategy
23.2.7. AbbVie Inc.
23.2.7.1. Overview
23.2.7.2. Product Portfolio
23.2.7.3. Profitability by Market Segments (Product/Channel/Region)
23.2.7.4. Sales Footprint
23.2.7.5. Strategy Overview
23.2.7.5.1. Marketing Strategy
23.2.7.5.2. Product Strategy
23.2.7.5.3. Channel Strategy
23.2.8. Pfizer Inc.
23.2.8.1. Overview
23.2.8.2. Product Portfolio
23.2.8.3. Profitability by Market Segments (Product/Channel/Region)
23.2.8.4. Sales Footprint
23.2.8.5. Strategy Overview
23.2.8.5.1. Marketing Strategy
23.2.8.5.2. Product Strategy
23.2.8.5.3. Channel Strategy
23.2.9. Mylan N.V.
23.2.9.1. Overview
23.2.9.2. Product Portfolio
23.2.9.3. Profitability by Market Segments (Product/Channel/Region)
23.2.9.4. Sales Footprint
23.2.9.5. Strategy Overview
23.2.9.5.1. Marketing Strategy
23.2.9.5.2. Product Strategy
23.2.9.5.3. Channel Strategy
23.2.10. Vetter Pharma-Fertigung GmbH & Co.KG
23.2.10.1. Overview
23.2.10.2. Product Portfolio
23.2.10.3. Profitability by Market Segments (Product/Channel/Region)
23.2.10.4. Sales Footprint
23.2.10.5. Strategy Overview
23.2.10.5.1. Marketing Strategy
23.2.10.5.2. Product Strategy
23.2.10.5.3. Channel Strategy
23.2.11. Emperra GmbH
23.2.11.1. Overview
23.2.11.2. Product Portfolio
23.2.11.3. Profitability by Market Segments (Product/Channel/Region)
23.2.11.4. Sales Footprint
23.2.11.5. Strategy Overview
23.2.11.5.1. Marketing Strategy
23.2.11.5.2. Product Strategy
23.2.11.5.3. Channel Strategy
23.2.12. Digital Medics Pty Ltd
23.2.12.1. Overview
23.2.12.2. Product Portfolio
23.2.12.3. Profitability by Market Segments (Product/Channel/Region)
23.2.12.4. Sales Footprint
23.2.12.5. Strategy Overview
23.2.12.5.1. Marketing Strategy
23.2.12.5.2. Product Strategy
23.2.12.5.3. Channel Strategy
23.2.13. Enable Injections LLC
23.2.13.1. Overview
23.2.13.2. Product Portfolio
23.2.13.3. Profitability by Market Segments (Product/Channel/Region)
23.2.13.4. Sales Footprint
23.2.13.5. Strategy Overview
23.2.13.5.1. Marketing Strategy
23.2.13.5.2. Product Strategy
23.2.13.5.3. Channel Strategy
23.2.14. Insulet corporation
23.2.14.1. Overview
23.2.14.2. Product Portfolio
23.2.14.3. Profitability by Market Segments (Product/Channel/Region)
23.2.14.4. Sales Footprint
23.2.14.5. Strategy Overview
23.2.14.5.1. Marketing Strategy
23.2.14.5.2. Product Strategy
23.2.14.5.3. Channel Strategy
23.2.15. Consort Medical Plc
23.2.15.1. Overview
23.2.15.2. Product Portfolio
23.2.15.3. Profitability by Market Segments (Product/Channel/Region)
23.2.15.4. Sales Footprint
23.2.15.5. Strategy Overview
23.2.15.5.1. Marketing Strategy
23.2.15.5.2. Product Strategy
23.2.15.5.3. Channel Strategy
23.2.16. Diabnext
23.2.16.1. Overview
23.2.16.2. Product Portfolio
23.2.16.3. Profitability by Market Segments (Product/Channel/Region)
23.2.16.4. Sales Footprint
23.2.16.5. Strategy Overview
23.2.16.5.1. Marketing Strategy
23.2.16.5.2. Product Strategy
23.2.16.5.3. Channel Strategy
23.2.17. Diamesco Co., Ltd
23.2.17.1. Overview
23.2.17.2. Product Portfolio
23.2.17.3. Profitability by Market Segments (Product/Channel/Region)
23.2.17.4. Sales Footprint
23.2.17.5. Strategy Overview
23.2.17.5.1. Marketing Strategy
23.2.17.5.2. Product Strategy
23.2.17.5.3. Channel Strategy
23.2.18. SCHOTT AG
23.2.18.1. Overview
23.2.18.2. Product Portfolio
23.2.18.3. Profitability by Market Segments (Product/Channel/Region)
23.2.18.4. Sales Footprint
23.2.18.5. Strategy Overview
23.2.18.5.1. Marketing Strategy
23.2.18.5.2. Product Strategy
23.2.18.5.3. Channel Strategy
23.2.19. SiO2 Medical Products
23.2.19.1. Overview
23.2.19.2. Product Portfolio
23.2.19.3. Profitability by Market Segments (Product/Channel/Region)
23.2.19.4. Sales Footprint
23.2.19.5. Strategy Overview
23.2.19.5.1. Marketing Strategy
23.2.19.5.2. Product Strategy
23.2.19.5.3. Channel Strategy
23.2.20. Integrity Bio, Inc.
23.2.20.1. Overview
23.2.20.2. Product Portfolio
23.2.20.3. Profitability by Market Segments (Product/Channel/Region)
23.2.20.4. Sales Footprint
23.2.20.5. Strategy Overview
23.2.20.5.1. Marketing Strategy
23.2.20.5.2. Product Strategy
23.2.20.5.3. Channel Strategy
23.2.21. Wilhelm Haselmeier GmbH & Co. KG
23.2.21.1. Overview
23.2.21.2. Product Portfolio
23.2.21.3. Profitability by Market Segments (Product/Channel/Region)
23.2.21.4. Sales Footprint
23.2.21.5. Strategy Overview
23.2.21.5.1. Marketing Strategy
23.2.21.5.2. Product Strategy
23.2.21.5.3. Channel Strategy
23.2.22. Tandem Diabetes Care
23.2.22.1. Overview
23.2.22.2. Product Portfolio
23.2.22.3. Profitability by Market Segments (Product/Channel/Region)
23.2.22.4. Sales Footprint
23.2.22.5. Strategy Overview
23.2.22.5.1. Marketing Strategy
23.2.22.5.2. Product Strategy
23.2.22.5.3. Channel Strategy
23.2.23. Sanofi S.A.
23.2.23.1. Overview
23.2.23.2. Product Portfolio
23.2.23.3. Profitability by Market Segments (Product/Channel/Region)
23.2.23.4. Sales Footprint
23.2.23.5. Strategy Overview
23.2.23.5.1. Marketing Strategy
23.2.23.5.2. Product Strategy
23.2.23.5.3. Channel Strategy
23.2.24. Companion Medical Inc.
23.2.24.1. Overview
23.2.24.2. Product Portfolio
23.2.24.3. Profitability by Market Segments (Product/Channel/Region)
23.2.24.4. Sales Footprint
23.2.24.5. Strategy Overview
23.2.24.5.1. Marketing Strategy
23.2.24.5.2. Product Strategy
23.2.24.5.3. Channel Strategy
23.2.25. Ypsomed
23.2.25.1. Overview
23.2.25.2. Product Portfolio
23.2.25.3. Profitability by Market Segments (Product/Channel/Region)
23.2.25.4. Sales Footprint
23.2.25.5. Strategy Overview
23.2.25.5.1. Marketing Strategy
23.2.25.5.2. Product Strategy
23.2.25.5.3. Channel Strategy
23.2.26. Hoffman – La Roche Ltd.
23.2.26.1. Overview
23.2.26.2. Product Portfolio
23.2.26.3. Profitability by Market Segments (Product/Channel/Region)
23.2.26.4. Sales Footprint
23.2.26.5. Strategy Overview
23.2.26.5.1. Marketing Strategy
23.2.26.5.2. Product Strategy
23.2.26.5.3. Channel Strategy
23.2.27. Novo Nordisk A/S
23.2.27.1. Overview
23.2.27.2. Product Portfolio
23.2.27.3. Profitability by Market Segments (Product/Channel/Region)
23.2.27.4. Sales Footprint
23.2.27.5. Strategy Overview
23.2.27.5.1. Marketing Strategy
23.2.27.5.2. Product Strategy
23.2.27.5.3. Channel Strategy
23.2.28. Medtronic Plc.
23.2.28.1. Overview
23.2.28.2. Product Portfolio
23.2.28.3. Profitability by Market Segments (Product/Channel/Region)
23.2.28.4. Sales Footprint
23.2.28.5. Strategy Overview
23.2.28.5.1. Marketing Strategy
23.2.28.5.2. Product Strategy
23.2.28.5.3. Channel Strategy
24. Assumptions and Acronyms Used
25. Research Methodology
List of TablesTable 02: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
Table 03: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 04: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
Table 05: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel
Table 06: Global Injectable Drug Delivery Market Value (US$ Bn) Analysis 2014–2018 and Forecast 2019–2029, by Region
Table 07: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country
Table 08: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type
Table 09: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
Table 10: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 11: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
Table 12: North America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel
Table 13: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country
Table 14: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type
Table 15: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
Table 16: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 17: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
Table 18: Latin America Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–018 and Forecast 2019–2029, by Distribution Channel
Table 19: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country
Table 20: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type
Table 21: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
able 22: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 23: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
Table 24: Europe Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel
Table 25: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country
Table 26: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type
Table 27: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
Table 28: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 29: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
able 30: South Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel
Table 31: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country
Table 32: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type
Table 33: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
Table 34: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 35: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
Table 36: East Asia Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel
Table 37: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country
Table 38: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type
Table 39: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
Table 40: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 41: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
Table 42: Oceania Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel
Table 43: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Country
Table 44: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Product Type
Table 45: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Technology
Table 46: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Usage
Table 47: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Indication
Table 48: MEA Injectable Drug Delivery Market Value (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, by Distribution Channel